🇺🇸 FDA
Pipeline program

C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.

C5951001

Phase 1 other active

Quick answer

C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors. for advanced solid tumors is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
advanced solid tumors
Phase
Phase 1
Modality
other
Status
active

Clinical trials